Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

LncRNA Arsa-DT is required for spermatogenesis and male fertility by regulating G2/M progression.

Created on 19 Oct 2026

Authors

Haena Choi, Ji-Eun Kim, Ju-Yeon Kim, Ho Lee, Mi-Ock Lee

Published in

iScience. Volume 29. Issue 11. Pages 117813. Nov 20, 2026. Epub Oct 08, 2026.

Abstract

Male infertility is a major reproductive health burden worldwide, yet its molecular etiology remains largely unknown. The testis expresses numerous long non-coding RNAs (lncRNAs), although their involvement in the pathophysiology of male infertility remains unexplored. Here, we identified Arsa-DT, a testis-predominant divergent lncRNA of Arsa, and demonstrated its essential role in maintaining male fertility. Loss of Arsa-DT leads to subfertility, characterized by reduced sperm production, increased sperm abnormalities, and decreased serum testosterone levels. Notably, Arsa-DT deficiency alters the testosterone-to-estradiol ratio through upregulation of aromatase expression. Specifically expressed in the nuclei of spermatogonia and spermatocytes, Arsa-DT regulates spermatogenesis in the seminiferous tubules. Mechanistically, Arsa-DT regulates G2/M phase progression and chromosome segregation in male germ cells. Collectively, our findings identify Arsa-DT, a testis-predominant lncRNA, as a regulator of spermatogenesis by controlling G2/M phase progression of male germ cells. This study provides mechanistic insights into the pathogenesis of male infertility.

PMID:
42894537
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement